To better understand how to construct a protective mucosal vaccine that could protect the earlier mucosal targets of influenza infection, we focused on CCL28, a chemokine that plays an important role in the migration of IgA ASCs in the mucosal sites27. The gene discussed is CD79A; the disease is influenza.